><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><collab>World Health Organisation</collab>. <source>Global Tuberculosis Report 2016</source>. <publisher-loc>Geneva</publisher-loc> (<year>2016</year>). p. <fpage>1</fpage>&#x02013;<lpage>201</lpage>.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name></person-group>. <article-title>The immune response in tuberculosis</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>475</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id><?supplied-pmid 23516984?><pub-id pub-id-type="pmid">23516984</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>(<issue>7309</issue>):<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cliff</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Constantinou</surname><given-names>N</given-names></name><name><surname>Cho</surname><given-names>JE</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Ronacher</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response</article-title>. <source>J Infect Dis</source> (<year>2013</year>) <volume>207</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jis499</pub-id><?supplied-pmid 22872737?><pub-id pub-id-type="pmid">22872737</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankley</surname><given-names>S</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Lipman</surname><given-names>M</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>. <article-title>The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source> (<year>2014</year>) <volume>369</volume>(<issue>1645</issue>):<fpage>20130427</fpage>.<pub-id pub-id-type="doi">10.1098/rstb.2013.0427</pub-id><?supplied-pmid 24821914?><pub-id pub-id-type="pmid">24821914</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankley</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Levin</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><etal/></person-group>
<article-title>A 380-gene meta-signature of active tuberculosis compared with healthy controls</article-title>. <source>Eur Respir J</source> (<year>2016</year>) <volume>47</volume>(<issue>6</issue>):<fpage>1873</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1183/13993003.02121-2015</pub-id><pub-id pub-id-type="pmid">27076596</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankley</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>(<issue>10</issue>):<fpage>e0162220</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0162220</pub-id><pub-id pub-id-type="pmid">27706152</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Penn-Nicholson</surname><given-names>A</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Thompson</surname><given-names>E</given-names></name><name><surname>Suliman</surname><given-names>S</given-names></name><name><surname>Amon</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>387</volume>(<issue>10035</issue>):<fpage>2312</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/s0140-6736(15)01316-1</pub-id><?supplied-pmid 27017310?><pub-id pub-id-type="pmid">27017310</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambarey</surname><given-names>A</given-names></name><name><surname>Devaprasad</surname><given-names>A</given-names></name><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Nayak</surname><given-names>S</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks</article-title>. <source>EBioMedicine</source> (<year>2017</year>) <volume>15</volume>:<fpage>112</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.ebiom.2016.12.009</pub-id><?supplied-pmid 28065665?><pub-id pub-id-type="pmid">28065665</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name></person-group>. <article-title>The yin and yang of type I interferon activity in bacterial infection</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>(<issue>9</issue>):<fpage>675</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1038/nri1684</pub-id><?supplied-pmid 16110316?><pub-id pub-id-type="pmid">16110316</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Weerd</surname><given-names>NA</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name></person-group>
<article-title>The interferons and their receptors &#x02013; distribution and regulation</article-title>. <source>Immunol Cell Biol</source> (<year>2012</year>) <volume>90</volume>(<issue>5</issue>):<fpage>483</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2012.9</pub-id><pub-id pub-id-type="pmid">22410872</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>. <article-title>The molecular basis for differential type I interferon signaling</article-title>. <source>J Biol Chem</source> (<year>2017</year>) <volume>292</volume>(<issue>18</issue>):<fpage>7285</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.R116.774562</pub-id><?supplied-pmid 28289098?><pub-id pub-id-type="pmid">28289098</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovarik</surname><given-names>P</given-names></name><name><surname>Castiglia</surname><given-names>V</given-names></name><name><surname>Ivin</surname><given-names>M</given-names></name><name><surname>Ebner</surname><given-names>F</given-names></name></person-group>. <article-title>Type I interferons in bacterial infections: a balancing act</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>652</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2016.00652</pub-id><?supplied-pmid 28082986?><pub-id pub-id-type="pmid">28082986</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>DT</given-names></name><name><surname>Hedges</surname><given-names>JF</given-names></name><name><surname>Jutila</surname><given-names>MA</given-names></name></person-group>
<article-title>Getting &#x0201c;inside&#x0201d; type I IFNs: type I IFNs in intracellular bacterial infections</article-title>. <source>J Immunol Res</source> (<year>2017</year>) <volume>2017</volume>:<fpage>9361802</fpage><pub-id pub-id-type="doi">10.1155/2017/9361802</pub-id><pub-id pub-id-type="pmid">28529959</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxx</surname><given-names>GM</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>. <article-title>The roles of type I interferon in bacterial infection</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>19</volume>(<issue>6</issue>):<fpage>760</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.05.016</pub-id><?supplied-pmid 27281568?><pub-id pub-id-type="pmid">27281568</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cliff</surname><given-names>JM</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name><name><surname>McShane</surname><given-names>H</given-names></name><name><surname>van Helden</surname><given-names>P</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>
<article-title>The human immune response to tuberculosis and its treatment: a view from the blood</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>264</volume>(<issue>1</issue>):<fpage>88</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12269</pub-id><pub-id pub-id-type="pmid">25703554</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deffur</surname><given-names>A</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Coussens</surname><given-names>AK</given-names></name></person-group>. <article-title>Tricks to translating TB transcriptomics</article-title>. <source>Ann Transl Med</source> (<year>2015</year>) <volume>3</volume>(<issue>Suppl 1</issue>):<fpage>S43</fpage>.<pub-id pub-id-type="doi">10.3978/j.issn.2305-5839.2015.04.12</pub-id><?supplied-pmid 26046091?><pub-id pub-id-type="pmid">26046091</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>CT</given-names></name><name><surname>Roe</surname><given-names>JK</given-names></name><name><surname>Pollara</surname><given-names>G</given-names></name><name><surname>Mehta</surname><given-names>M</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name></person-group>. <article-title>Diagnostic &#x02019;omics&#x02019; for active tuberculosis</article-title>. <source>BMC Med</source> (<year>2016</year>) <volume>14</volume>:<fpage>37</fpage>.<pub-id pub-id-type="doi">10.1186/s12916-016-0583-9</pub-id><?supplied-pmid 27005907?><pub-id pub-id-type="pmid">27005907</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>9</issue>):<fpage>e73230</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0073230</pub-id><?supplied-pmid 24066041?><pub-id pub-id-type="pmid">24066041</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>McEwen</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Lader</surname><given-names>E</given-names></name><name><surname>Schriek</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Concise gene signature for point-of-care classification of tuberculosis</article-title>. <source>EMBO Mol Med</source> (<year>2016</year>) <volume>8</volume>(<issue>2</issue>):<fpage>86</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.15252/emmm.201505790</pub-id><?supplied-pmid 26682570?><pub-id pub-id-type="pmid">26682570</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>JK</given-names></name><name><surname>Thomas</surname><given-names>N</given-names></name><name><surname>Gil</surname><given-names>E</given-names></name><name><surname>Best</surname><given-names>K</given-names></name><name><surname>Tsaliki</surname><given-names>E</given-names></name><name><surname>Morris-Jones</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis</article-title>. <source>JCI Insight</source> (<year>2016</year>) <volume>1</volume>(<issue>16</issue>):<fpage>e87238</fpage>.<pub-id pub-id-type="doi">10.1172/jci.insight.87238</pub-id><?supplied-pmid 27734027?><pub-id pub-id-type="pmid">27734027</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>TE</given-names></name><name><surname>Braviak</surname><given-names>L</given-names></name><name><surname>Tato</surname><given-names>CM</given-names></name><name><surname>Khatri</surname><given-names>P</given-names></name></person-group>. <article-title>Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis</article-title>. <source>Lancet Respir Med</source> (<year>2016</year>) <volume>4</volume>(<issue>3</issue>):<fpage>213</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/s2213-2600(16)00048-5</pub-id><?supplied-pmid 26907218?><pub-id pub-id-type="pmid">26907218</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattamanchi</surname><given-names>A</given-names></name><name><surname>Walter</surname><given-names>ND</given-names></name><name><surname>Metcalfe</surname><given-names>JZ</given-names></name><name><surname>Davis</surname><given-names>JL</given-names></name></person-group>. <article-title>A transcriptional signature for active TB: have we found the needle in the haystack?</article-title>
<source>PLoS Med</source> (<year>2013</year>) <volume>10</volume>(<issue>10</issue>):<fpage>e1001539</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pmed.1001539</pub-id><?supplied-pmid 24167454?><pub-id pub-id-type="pmid">24167454</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harries</surname><given-names>AD</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Satyanarayana</surname><given-names>S</given-names></name><name><surname>Lonnroth</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis</article-title>. <source>Int J Tuberc Lung Dis</source> (<year>2011</year>) <volume>15</volume>(<issue>11</issue>):<fpage>1436</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.5588/ijtld.11.0503</pub-id><?supplied-pmid 21902876?><pub-id pub-id-type="pmid">21902876</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prada-Medina</surname><given-names>CA</given-names></name><name><surname>Fukutani</surname><given-names>KF</given-names></name><name><surname>Pavan Kumar</surname><given-names>N</given-names></name><name><surname>Gil-Santana</surname><given-names>L</given-names></name><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Lichtenstein</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>(<issue>1</issue>):<fpage>1999</fpage>.<pub-id pub-id-type="doi">10.1038/s41598-017-01767-4</pub-id><?supplied-pmid 28515464?><pub-id pub-id-type="pmid">28515464</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koth</surname><given-names>LL</given-names></name><name><surname>Solberg</surname><given-names>OD</given-names></name><name><surname>Peng</surname><given-names>JC</given-names></name><name><surname>Bhakta</surname><given-names>NR</given-names></name><name><surname>Nguyen</surname><given-names>CP</given-names></name><name><surname>Woodruff</surname><given-names>PG</given-names></name></person-group>. <article-title>Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2011</year>) <volume>184</volume>(<issue>10</issue>):<fpage>1153</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201106-1143OC</pub-id><?supplied-pmid 21852540?><pub-id pub-id-type="pmid">21852540</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><name><surname>Bauer</surname><given-names>T</given-names></name><name><surname>Prasse</surname><given-names>A</given-names></name><name><surname>Muller-Quernheim</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Common patterns and disease-related signatures in tuberculosis and sarcoidosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>(<issue>20</issue>):<fpage>7853</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1121072109</pub-id><?supplied-pmid 22547807?><pub-id pub-id-type="pmid">22547807</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Rozakeas</surname><given-names>F</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>8</issue>):<fpage>e70630</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0070630</pub-id><?supplied-pmid 23940611?><pub-id pub-id-type="pmid">23940611</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>GC</given-names></name><name><surname>Schreiber</surname><given-names>MF</given-names></name><name><surname>Bautista</surname><given-names>R</given-names></name><name><surname>Maude</surname><given-names>RR</given-names></name><name><surname>Dunachie</surname><given-names>S</given-names></name><name><surname>Limmathurotsakul</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>1</issue>):<fpage>e54961</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0054961</pub-id><?supplied-pmid 23383015?><pub-id pub-id-type="pmid">23383015</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaforou</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>VJ</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>French</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>ST</given-names></name><name><surname>Bangani</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study</article-title>. <source>PLoS Med</source> (<year>2013</year>) <volume>10</volume>(<issue>10</issue>):<fpage>e1001538</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pmed.1001538</pub-id><?supplied-pmid 24167453?><pub-id pub-id-type="pmid">24167453</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remoli</surname><given-names>ME</given-names></name><name><surname>Giacomini</surname><given-names>E</given-names></name><name><surname>Lutfalla</surname><given-names>G</given-names></name><name><surname>Dondi</surname><given-names>E</given-names></name><name><surname>Orefici</surname><given-names>G</given-names></name><name><surname>Battistini</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Selective expression of type I IFN genes in human dendritic cells infected with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>(<issue>1</issue>):<fpage>366</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.169.1.366</pub-id><?supplied-pmid 12077266?><pub-id pub-id-type="pmid">12077266</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Blumenthal</surname><given-names>A</given-names></name><name><surname>Hickey</surname><given-names>CM</given-names></name><name><surname>Gandotra</surname><given-names>S</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name></person-group>. <article-title>Expression of many immunologically important genes in <italic>Mycobacterium tuberculosis</italic>-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>175</volume>(<issue>5</issue>):<fpage>3318</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.175.5.3318</pub-id><?supplied-pmid 16116224?><pub-id pub-id-type="pmid">16116224</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SA</given-names></name><name><surname>Johndrow</surname><given-names>JE</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group>. <article-title>The Type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>(<issue>5</issue>):<fpage>3143</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3143</pub-id><?supplied-pmid 17312162?><pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A</given-names></name><name><surname>Cardone</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Kirschman</surname><given-names>KD</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>(<issue>5</issue>):<fpage>2540</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1100926</pub-id><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>B</given-names></name><name><surname>Dey</surname><given-names>RJ</given-names></name><name><surname>Cheung</surname><given-names>LS</given-names></name><name><surname>Pokkali</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>(<issue>4</issue>):<fpage>401</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3813</pub-id><?supplied-pmid 25730264?><pub-id pub-id-type="pmid">25730264</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etna</surname><given-names>MP</given-names></name><name><surname>Giacomini</surname><given-names>E</given-names></name><name><surname>Pardini</surname><given-names>M</given-names></name><name><surname>Severa</surname><given-names>M</given-names></name><name><surname>Bottai</surname><given-names>D</given-names></name><name><surname>Cruciani</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Impact of <italic>Mycobacterium tuberculosis</italic> RD1-locus on human primary dendritic cell immune functions</article-title>. <source>Sci Rep</source> (<year>2015</year>) <volume>5</volume>:<fpage>17078</fpage>.<pub-id pub-id-type="doi">10.1038/srep17078</pub-id><?supplied-pmid 26602835?><pub-id pub-id-type="pmid">26602835</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassermann</surname><given-names>R</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Perin</surname><given-names>SG</given-names></name><name><surname>Lou</surname><given-names>Y</given-names></name><name><surname>Rybniker</surname><given-names>J</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>(<issue>6</issue>):<fpage>799</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.003</pub-id><?supplied-pmid 26048138?><pub-id pub-id-type="pmid">26048138</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>RO</given-names></name><name><surname>Bell</surname><given-names>SL</given-names></name><name><surname>MacDuff</surname><given-names>DA</given-names></name><name><surname>Kimmey</surname><given-names>JM</given-names></name><name><surname>Diner</surname><given-names>EJ</given-names></name><name><surname>Olivas</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The cytosolic sensor cGAS detects <italic>Mycobacterium tuberculosis</italic> DNA to induce type I interferons and activate autophagy</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>(<issue>6</issue>):<fpage>811</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.004</pub-id><?supplied-pmid 26048136?><pub-id pub-id-type="pmid">26048136</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name><name><surname>Coulombe</surname><given-names>F</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>(<issue>7</issue>):<fpage>e1000500</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id><?supplied-pmid 19578435?><pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wathelet</surname><given-names>MG</given-names></name><name><surname>Lin</surname><given-names>CH</given-names></name><name><surname>Parekh</surname><given-names>BS</given-names></name><name><surname>Ronco</surname><given-names>LV</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name></person-group>. <article-title>Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo</article-title>. <source>Mol Cell</source> (<year>1998</year>) <volume>1</volume>(<issue>4</issue>):<fpage>507</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1016/S1097-2765(00)80051-9</pub-id><?supplied-pmid 9660935?><pub-id pub-id-type="pmid">9660935</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groschel</surname><given-names>MI</given-names></name><name><surname>Sayes</surname><given-names>F</given-names></name><name><surname>Simeone</surname><given-names>R</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name></person-group>. <article-title>ESX secretion systems: mycobacterial evolution to counter host immunity</article-title>. <source>Nat Rev Microbiol</source> (<year>2016</year>) <volume>14</volume>(<issue>11</issue>):<fpage>677</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro.2016.131</pub-id><?supplied-pmid 27665717?><pub-id pub-id-type="pmid">27665717</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname><given-names>WH</given-names></name><name><surname>Osman</surname><given-names>MM</given-names></name><name><surname>Shanahan</surname><given-names>JK</given-names></name><name><surname>Chu</surname><given-names>F</given-names></name><name><surname>Takaki</surname><given-names>KK</given-names></name><name><surname>Cameron</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2017</year>) <volume>114</volume>(<issue>6</issue>):<fpage>1371</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1620133114</pub-id><?supplied-pmid 28119503?><pub-id pub-id-type="pmid">28119503</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiens</surname><given-names>KE</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>
<article-title>The mechanism for type I interferon induction by <italic>Mycobacterium tuberculosis</italic> is bacterial strain-dependent</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>(<issue>8</issue>):<fpage>e1005809</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005809</pub-id><pub-id pub-id-type="pmid">27500737</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simeone</surname><given-names>R</given-names></name><name><surname>Bobard</surname><given-names>A</given-names></name><name><surname>Lippmann</surname><given-names>J</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Phagosomal rupture by <italic>Mycobacterium tuberculosis</italic> results in toxicity and host cell death</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>(<issue>2</issue>):<fpage>e1002507</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002507</pub-id><?supplied-pmid 22319448?><pub-id pub-id-type="pmid">22319448</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>RO</given-names></name><name><surname>Manzanillo</surname><given-names>PS</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group>. <article-title>Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway</article-title>. <source>Cell</source> (<year>2012</year>) <volume>150</volume>(<issue>4</issue>):<fpage>803</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2012.06.040</pub-id><?supplied-pmid 22901810?><pub-id pub-id-type="pmid">22901810</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leber</surname><given-names>JH</given-names></name><name><surname>Crimmins</surname><given-names>GT</given-names></name><name><surname>Raghavan</surname><given-names>S</given-names></name><name><surname>Meyer-Morse</surname><given-names>NP</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>. <article-title>Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen</article-title>. <source>PLoS Pathog</source> (<year>2008</year>) <volume>4</volume>(<issue>1</issue>):<fpage>e6</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.0040006</pub-id><?supplied-pmid 18193943?><pub-id pub-id-type="pmid">18193943</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandotra</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name></person-group>. <article-title>Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Infect Immun</source> (<year>2007</year>) <volume>75</volume>(<issue>11</issue>):<fpage>5127</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1128/iai.00458-07</pub-id><?supplied-pmid 17709422?><pub-id pub-id-type="pmid">17709422</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Coulombe</surname><given-names>F</given-names></name><name><surname>Kozak</surname><given-names>R</given-names></name><name><surname>Guillot</surname><given-names>L</given-names></name><name><surname>Veyrier</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>NOD2-deficient mice have impaired resistance to <italic>Mycobacterium tuberculosis</italic> infection through defective innate and adaptive immunity</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>10</issue>):<fpage>7157</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.10.7157</pub-id><?supplied-pmid 18981137?><pub-id pub-id-type="pmid">18981137</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>CM</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Graviss</surname><given-names>EA</given-names></name></person-group>. <article-title>Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans</article-title>. <source>J Infect Dis</source> (<year>2008</year>) <volume>197</volume>(<issue>12</issue>):<fpage>1713</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1086/588384</pub-id><?supplied-pmid 18419343?><pub-id pub-id-type="pmid">18419343</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population</article-title>. <source>Int J Immunogenet</source> (<year>2012</year>) <volume>39</volume>(<issue>3</issue>):<fpage>233</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1111/j.1744-313X.2011.01079.x</pub-id><?supplied-pmid 22212192?><pub-id pub-id-type="pmid">22212192</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Gaur</surname><given-names>R</given-names></name><name><surname>Mittal</surname><given-names>M</given-names></name><name><surname>Biswas</surname><given-names>SK</given-names></name><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Girdhar</surname><given-names>BK</given-names></name><etal/></person-group>
<article-title>Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis</article-title>. <source>Int J Immunogenet</source> (<year>2012</year>) <volume>39</volume>(<issue>4</issue>):<fpage>353</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/j.1744-313X.2012.01085.x</pub-id><?supplied-pmid 22289211?><pub-id pub-id-type="pmid">22289211</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>A novel single nucleotide polymorphism within the NOD2 gene is associated with pulmonary tuberculosis in the Chinese Han, Uygur and Kazak populations</article-title>. <source>BMC Infect Dis</source> (<year>2012</year>) <volume>12</volume>:<fpage>91</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-12-91</pub-id><?supplied-pmid 22502597?><pub-id pub-id-type="pmid">22502597</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>ZL</given-names></name><name><surname>Pan</surname><given-names>ZF</given-names></name><name><surname>Wei</surname><given-names>LL</given-names></name><name><surname>Xu</surname><given-names>DD</given-names></name><name><surname>Jiang</surname><given-names>TT</given-names></name><etal/></person-group>
<article-title>NOD2 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis</article-title>. <source>Int J Biol Sci</source> (<year>2013</year>) <volume>10</volume>(<issue>1</issue>):<fpage>103</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.7150/ijbs.7585</pub-id><pub-id pub-id-type="pmid">24391456</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>AC</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Nair</surname><given-names>VR</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP synthase is an innate immune DNA sensor for <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>(<issue>6</issue>):<fpage>820</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.005</pub-id><?supplied-pmid 26048137?><pub-id pub-id-type="pmid">26048137</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>10</issue>):<fpage>1142</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3558</pub-id><?supplied-pmid 27648547?><pub-id pub-id-type="pmid">27648547</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ablasser</surname><given-names>A</given-names></name><name><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name><surname>Hemmerling</surname><given-names>I</given-names></name><name><surname>Horvath</surname><given-names>GL</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP</article-title>. <source>Nature</source> (<year>2013</year>) <volume>503</volume>(<issue>7477</issue>):<fpage>530</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature12640</pub-id><?supplied-pmid 24077100?><pub-id pub-id-type="pmid">24077100</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdette</surname><given-names>DL</given-names></name><name><surname>Monroe</surname><given-names>KM</given-names></name><name><surname>Sotelo-Troha</surname><given-names>K</given-names></name><name><surname>Iwig</surname><given-names>JS</given-names></name><name><surname>Eckert</surname><given-names>B</given-names></name><name><surname>Hyodo</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>STING is a direct innate immune sensor of cyclic di-GMP</article-title>. <source>Nature</source> (<year>2011</year>) <volume>478</volume>(<issue>7370</issue>):<fpage>515</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nature10429</pub-id><?supplied-pmid 21947006?><pub-id pub-id-type="pmid">21947006</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Eisele</surname><given-names>LE</given-names></name><name><surname>Bai</surname><given-names>G</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic> Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-di-AMP</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>4</issue>):<fpage>e35206</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0035206</pub-id><?supplied-pmid 22529992?><pub-id pub-id-type="pmid">22529992</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gabrielle</surname><given-names>VD</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Bai</surname><given-names>G</given-names></name></person-group>. <article-title>Deletion of the cyclic di-AMP phosphodiesterase gene (cnpB) in <italic>Mycobacterium tuberculosis</italic> leads to reduced virulence in a mouse model of infection</article-title>. <source>Mol Microbiol</source> (<year>2014</year>) <volume>93</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1111/mmi.12641</pub-id><?supplied-pmid 24806618?><pub-id pub-id-type="pmid">24806618</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>RJ</given-names></name><name><surname>Dey</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>LS</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Sayre</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Inhibition of innate immune cytosolic surveillance by an <italic>M. tuberculosis</italic> phosphodiesterase</article-title>. <source>Nat Chem Biol</source> (<year>2017</year>) <volume>13</volume>(<issue>2</issue>):<fpage>210</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nchembio.2254</pub-id><?supplied-pmid 28106876?><pub-id pub-id-type="pmid">28106876</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvatiyar</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Ouyang</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Iyer</surname><given-names>SS</given-names></name><etal/></person-group>
<article-title>The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>12</issue>):<fpage>1155</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2460</pub-id><?supplied-pmid 23142775?><pub-id pub-id-type="pmid">23142775</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>AP</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name><name><surname>Ahmed-Qadri</surname><given-names>F</given-names></name><name><surname>Zuck</surname><given-names>M</given-names></name><name><surname>Thayer</surname><given-names>EF</given-names></name><name><surname>Goo</surname><given-names>YA</given-names></name><etal/></person-group>
<article-title>Sensing of bacterial cyclic dinucleotides by the oxidoreductase RECON promotes NF-kappaB activation and shapes a proinflammatory antibacterial state</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>46</volume>(<issue>3</issue>):<fpage>433</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2017.02.014</pub-id><pub-id pub-id-type="pmid">28329705</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Seo</surname><given-names>GJ</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Kwak</surname><given-names>MJ</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Rodgers</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses</article-title>. <source>Cell Host Microbe</source> (<year>2014</year>) <volume>15</volume>(<issue>2</issue>):<fpage>228</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2014.01.009</pub-id><?supplied-pmid 24528868?><pub-id pub-id-type="pmid">24528868</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Prados-Rosales</surname><given-names>R</given-names></name><name><surname>Casadevall</surname><given-names>A</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name></person-group>. <article-title>Release of mycobacterial antigens</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>264</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12251</pub-id><?supplied-pmid 25703550?><pub-id pub-id-type="pmid">25703550</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>Toll-like receptors and their crosstalk with other innate receptors in infection and immunity</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>(<issue>5</issue>):<fpage>637</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.006</pub-id><?supplied-pmid 21616434?><pub-id pub-id-type="pmid">21616434</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botos</surname><given-names>I</given-names></name><name><surname>Segal</surname><given-names>DM</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name></person-group>. <article-title>The structural biology of toll-like receptors</article-title>. <source>Structure</source> (<year>2011</year>) <volume>19</volume>(<issue>4</issue>):<fpage>447</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1016/j.str.2011.02.004</pub-id><?supplied-pmid 21481769?><pub-id pub-id-type="pmid">21481769</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name></person-group>
<article-title>Structural biology of the toll-like receptor family</article-title>. <source>Annu Rev Biochem</source> (<year>2011</year>) <volume>80</volume>:<fpage>917</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-biochem-052909-141507</pub-id><pub-id pub-id-type="pmid">21548780</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>LA</given-names></name><name><surname>Golenbock</surname><given-names>D</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name></person-group>. <article-title>The history of toll-like receptors &#x02013; redefining innate immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>(<issue>6</issue>):<fpage>453</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/nri3446</pub-id><?supplied-pmid 23681101?><pub-id pub-id-type="pmid">23681101</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname><given-names>JC</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Horng</surname><given-names>T</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>. <article-title>TRAM couples endocytosis of toll-like receptor 4 to the induction of interferon-beta</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>(<issue>4</issue>):<fpage>361</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/ni1569</pub-id><?supplied-pmid 18297073?><pub-id pub-id-type="pmid">18297073</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MG</given-names></name><name><surname>McAlpine</surname><given-names>SM</given-names></name><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>Haidl</surname><given-names>ID</given-names></name><name><surname>Al-Afif</surname><given-names>A</given-names></name><name><surname>Marshall</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>3</issue>):<fpage>e34055</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0034055</pub-id><?supplied-pmid 22479521?><pub-id pub-id-type="pmid">22479521</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsen</surname><given-names>NJ</given-names></name><name><surname>Vladimer</surname><given-names>GI</given-names></name><name><surname>Stenvik</surname><given-names>J</given-names></name><name><surname>Orning</surname><given-names>MP</given-names></name><name><surname>Zeid-Kilani</surname><given-names>MV</given-names></name><name><surname>Bugge</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling</article-title>. <source>J Biol Chem</source> (<year>2015</year>) <volume>290</volume>(<issue>6</issue>):<fpage>3209</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M114.593426</pub-id><pub-id pub-id-type="pmid">25505250</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona</surname><given-names>J</given-names></name><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Sousa</surname><given-names>C</given-names></name><name><surname>Sousa</surname><given-names>J</given-names></name><name><surname>Osorio</surname><given-names>NS</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> strains are differentially recognized by TLRs with an impact on the immune response</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>6</issue>):<fpage>e67277</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0067277</pub-id><?supplied-pmid 23840651?><pub-id pub-id-type="pmid">23840651</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Sousa</surname><given-names>J</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Cardoso</surname><given-names>F</given-names></name><name><surname>Machado</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Type I IFN inhibits alternative macrophage activation during <italic>Mycobacterium tuberculosis</italic> infection and leads to enhanced protection in the absence of IFN-gamma signaling</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>(<issue>12</issue>):<fpage>4714</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1600584</pub-id><pub-id pub-id-type="pmid">27849167</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>G</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>de Jong</surname><given-names>DJ</given-names></name><name><surname>Girardin</surname><given-names>SE</given-names></name><name><surname>Langenberg</surname><given-names>DM</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium paratuberculosis</italic> is recognized by toll-like receptors and NOD2</article-title>. <source>J Leukoc Biol</source> (<year>2007</year>) <volume>82</volume>(<issue>4</issue>):<fpage>1011</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0307147</pub-id><?supplied-pmid 17652449?><pub-id pub-id-type="pmid">17652449</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulido</surname><given-names>I</given-names></name><name><surname>Leal</surname><given-names>M</given-names></name><name><surname>Genebat</surname><given-names>M</given-names></name><name><surname>Pacheco</surname><given-names>YM</given-names></name><name><surname>Saez</surname><given-names>ME</given-names></name><name><surname>Soriano-Sarabia</surname><given-names>N</given-names></name></person-group>. <article-title>The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients</article-title>. <source>Curr HIV Res</source> (<year>2010</year>) <volume>8</volume>(<issue>3</issue>):<fpage>253</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2174/157016210791111052</pub-id><?supplied-pmid 20226000?><pub-id pub-id-type="pmid">20226000</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogus</surname><given-names>AC</given-names></name><name><surname>Yoldas</surname><given-names>B</given-names></name><name><surname>Ozdemir</surname><given-names>T</given-names></name><name><surname>Uguz</surname><given-names>A</given-names></name><name><surname>Olcen</surname><given-names>S</given-names></name><name><surname>Keser</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease</article-title>. <source>Eur Respir J</source> (<year>2004</year>) <volume>23</volume>(<issue>2</issue>):<fpage>219</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.03.00061703</pub-id><?supplied-pmid 14979495?><pub-id pub-id-type="pmid">14979495</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gowen</surname><given-names>BB</given-names></name><name><surname>Graviss</surname><given-names>EA</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name></person-group>. <article-title>Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease</article-title>. <source>PLoS One</source> (<year>2007</year>) <volume>2</volume>(<issue>12</issue>):<fpage>e1318</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0001318</pub-id><?supplied-pmid 18091991?><pub-id pub-id-type="pmid">18091991</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etokebe</surname><given-names>GE</given-names></name><name><surname>Skjeldal</surname><given-names>F</given-names></name><name><surname>Nilsen</surname><given-names>N</given-names></name><name><surname>Rodionov</surname><given-names>D</given-names></name><name><surname>Knezevic</surname><given-names>J</given-names></name><name><surname>Bulat-Kardum</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele</article-title>. <source>Scand J Immunol</source> (<year>2010</year>) <volume>71</volume>(<issue>5</issue>):<fpage>369</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3083.2010.02379.x</pub-id><?supplied-pmid 20500688?><pub-id pub-id-type="pmid">20500688</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>AZ</given-names></name><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YX</given-names></name><etal/></person-group>
<article-title>Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese</article-title>. <source>Clin Chem Lab Med</source> (<year>2010</year>) <volume>48</volume>(<issue>6</issue>):<fpage>785</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1515/cclm.2010.154</pub-id><pub-id pub-id-type="pmid">20298136</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalgic</surname><given-names>N</given-names></name><name><surname>Tekin</surname><given-names>D</given-names></name><name><surname>Kayaalti</surname><given-names>Z</given-names></name><name><surname>Soylemezoglu</surname><given-names>T</given-names></name><name><surname>Cakir</surname><given-names>E</given-names></name><name><surname>Kilic</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Arg753Gln polymorphism of the human toll-like receptor 2 gene from infection to disease in pediatric tuberculosis</article-title>. <source>Hum Immunol</source> (<year>2011</year>) <volume>72</volume>(<issue>5</issue>):<fpage>440</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.humimm.2011.02.001</pub-id><?supplied-pmid 21320563?><pub-id pub-id-type="pmid">21320563</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>SD</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>XZ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Meta-analysis on the associations of TLR2 gene polymorphisms with pulmonary tuberculosis susceptibility among Asian populations</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>10</issue>):<fpage>e75090</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0075090</pub-id><pub-id pub-id-type="pmid">24124467</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>S</given-names></name><name><surname>Hibberd</surname><given-names>ML</given-names></name><name><surname>Hari Dass</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>HE</given-names></name><name><surname>Sahiratmadja</surname><given-names>E</given-names></name><name><surname>Bonnard</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis</article-title>. <source>PLoS Genet</source> (<year>2008</year>) <volume>4</volume>(<issue>10</issue>):<fpage>e1000218</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pgen.1000218</pub-id><?supplied-pmid 18927625?><pub-id pub-id-type="pmid">18927625</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>DR</given-names></name><name><surname>Wejse</surname><given-names>C</given-names></name><name><surname>Stryjewski</surname><given-names>ME</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>Hulme</surname><given-names>WF</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title>Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans</article-title>. <source>Hum Genet</source> (<year>2010</year>) <volume>127</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1007/s00439-009-0741-7</pub-id><pub-id pub-id-type="pmid">19771452</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>ZQ</given-names></name><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>CP</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis</article-title>. <source>Int J Immunogenet</source> (<year>2010</year>) <volume>37</volume>(<issue>2</issue>):<fpage>135</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1744-313X.2009.00892.x</pub-id><pub-id pub-id-type="pmid">20002809</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LA</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Van Crevel</surname><given-names>R</given-names></name></person-group>. <article-title>Innate immune recognition of <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Clin Dev Immunol</source> (<year>2011</year>) <volume>2011</volume>:<fpage>405310</fpage>.<pub-id pub-id-type="doi">10.1155/2011/405310</pub-id><?supplied-pmid 21603213?><pub-id pub-id-type="pmid">21603213</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name></person-group>. <article-title>Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis</article-title>. <source>BMC Pulm Med</source> (<year>2015</year>) <volume>15</volume>:<fpage>57</fpage>.<pub-id pub-id-type="doi">10.1186/s12890-015-0049-4</pub-id><?supplied-pmid 25948535?><pub-id pub-id-type="pmid">25948535</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurz</surname><given-names>H</given-names></name><name><surname>Daya</surname><given-names>M</given-names></name><name><surname>Moller</surname><given-names>M</given-names></name><name><surname>Hoal</surname><given-names>EG</given-names></name><name><surname>Salie</surname><given-names>M</given-names></name></person-group>. <article-title>TLR1, 2, 4, 6 and 9 variants associated with tuberculosis susceptibility: a systematic review and meta-analysis</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>(<issue>10</issue>):<fpage>e0139711</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0139711</pub-id><?supplied-pmid 26430737?><pub-id pub-id-type="pmid">26430737</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindler</surname><given-names>C</given-names></name><name><surname>Levy</surname><given-names>DE</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name></person-group>
<article-title>JAK-STAT signaling: from interferons to cytokines</article-title>. <source>J Biol Chem</source> (<year>2007</year>) <volume>282</volume>(<issue>28</issue>):<fpage>20059</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.R700016200</pub-id><pub-id pub-id-type="pmid">17502367</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Bergtold</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2001</year>) <volume>98</volume>(<issue>10</issue>):<fpage>5752</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><?supplied-pmid 11320211?><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>. <source>J Interferon Cytokine Res</source> (<year>2005</year>) <volume>25</volume>(<issue>11</issue>):<fpage>694</fpage>&#x02013;<lpage>701</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2005.25.694</pub-id><?supplied-pmid 16318583?><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>8</issue>):<fpage>2380</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id><?supplied-pmid 24782112?><pub-id pub-id-type="pmid">24782112</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Oland</surname><given-names>SD</given-names></name><name><surname>Amaral</surname><given-names>EP</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Gonzales</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source> (<year>2014</year>) <volume>511</volume>(<issue>7507</issue>):<fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nature13489</pub-id><?supplied-pmid 24990750?><pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordway</surname><given-names>D</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M</given-names></name><name><surname>Harton</surname><given-names>M</given-names></name><name><surname>Palanisamy</surname><given-names>G</given-names></name><name><surname>Troudt</surname><given-names>J</given-names></name><name><surname>Shanley</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The hypervirulent <italic>Mycobacterium tuberculosis</italic> strain HN878 induces a potent TH1 response followed by rapid down-regulation</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>1</issue>):<fpage>522</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.1.522</pub-id><?supplied-pmid 17579073?><pub-id pub-id-type="pmid">17579073</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>. <article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>(<issue>12</issue>):<fpage>6205</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1200255</pub-id><?supplied-pmid 22566567?><pub-id pub-id-type="pmid">22566567</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiens</surname><given-names>KE</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>
<article-title>Type I interferon is pathogenic during chronic <italic>Mycobacterium africanum</italic> Infection</article-title>. <source>J Infect Dis</source> (<year>2016</year>) <volume>214</volume>(<issue>12</issue>):<fpage>1893</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiw519</pub-id><pub-id pub-id-type="pmid">27803172</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Stavropoulos</surname><given-names>E</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>(<issue>2</issue>):<fpage>270</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit424</pub-id><?supplied-pmid 23935205?><pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A</given-names></name><name><surname>Goncalves</surname><given-names>R</given-names></name><name><surname>Roffe</surname><given-names>E</given-names></name><name><surname>Cheever</surname><given-names>AW</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>(<issue>5</issue>):<fpage>1674</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1172/jci40817</pub-id><?supplied-pmid 20389020?><pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M</given-names></name></person-group>. <article-title>Recombinant murine beta interferon enhances resistance of mice to systemic <italic>Mycobacterium avium</italic> infection</article-title>. <source>Infect Immun</source> (<year>1991</year>) <volume>59</volume>(<issue>5</issue>):<fpage>1857</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 2019446?><pub-id pub-id-type="pmid">2019446</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuchtey</surname><given-names>J</given-names></name><name><surname>Fulton</surname><given-names>SA</given-names></name><name><surname>Reba</surname><given-names>SM</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group>
<article-title>Interferon-alphabeta mediates partial control of early pulmonary <italic>Mycobacterium bovis</italic> bacillus Calmette-Guerin infection</article-title>. <source>Immunology</source> (<year>2006</year>) <volume>118</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2006.02337.x</pub-id><pub-id pub-id-type="pmid">16630021</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruangkiattikul</surname><given-names>N</given-names></name><name><surname>Nerlich</surname><given-names>A</given-names></name><name><surname>Abdissa</surname><given-names>K</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name><name><surname>Suwandi</surname><given-names>A</given-names></name><name><surname>Janze</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>cGAS-STING-TBK1-IRF3/7 induced interferon-beta contributes to the clearing of non tuberculous mycobacterial infection in mice</article-title>. <source>Virulence</source> (<year>2017</year>) <volume>19</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1080/21505594.2017.1321191</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>JV</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group>
<article-title>Expression of the nitric oxide synthase 2 gene is not essential for early control of <italic>Mycobacterium tuberculosis</italic> in the murine lung</article-title>. <source>Infect Immun</source> (<year>2000</year>) <volume>68</volume>(<issue>12</issue>):<fpage>6879</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.68.12.6879-6882.2000</pub-id><pub-id pub-id-type="pmid">11083808</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>CM</given-names></name><name><surname>Jyonouchi</surname><given-names>H</given-names></name><name><surname>Kotenko</surname><given-names>SV</given-names></name><name><surname>Smirnov</surname><given-names>SV</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Aguila</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Adjunctive treatment of disseminated <italic>Mycobacterium avium</italic> complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency</article-title>. <source>Eur J Pediatr</source> (<year>2007</year>) <volume>166</volume>(<issue>9</issue>):<fpage>981</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1007/s00431-006-0339-1</pub-id><?supplied-pmid 17120031?><pub-id pub-id-type="pmid">17120031</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bax</surname><given-names>HI</given-names></name><name><surname>Freeman</surname><given-names>AF</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Hsu</surname><given-names>AP</given-names></name><name><surname>Marciano</surname><given-names>B</given-names></name><name><surname>Kristosturyan</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Interferon alpha treatment of patients with impaired interferon gamma signaling</article-title>. <source>J Clin Immunol</source> (<year>2013</year>) <volume>33</volume>(<issue>5</issue>):<fpage>991</fpage>&#x02013;<lpage>1001</lpage>.<pub-id pub-id-type="doi">10.1007/s10875-013-9882-5</pub-id><?supplied-pmid 23512243?><pub-id pub-id-type="pmid">23512243</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Lu</surname><given-names>PL</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>WR</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><etal/></person-group>
<article-title>Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan</article-title>. <source>BMC Infect Dis</source> (<year>2014</year>) <volume>14</volume>:<fpage>705</fpage>.<pub-id pub-id-type="doi">10.1186/s12879-014-0705-y</pub-id><?supplied-pmid 25523602?><pub-id pub-id-type="pmid">25523602</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbatani</surname><given-names>S</given-names></name><name><surname>Manfredi</surname><given-names>R</given-names></name><name><surname>Marinacci</surname><given-names>G</given-names></name><name><surname>Pavoni</surname><given-names>M</given-names></name><name><surname>Cristoni</surname><given-names>L</given-names></name><name><surname>Chiodo</surname><given-names>F</given-names></name></person-group>. <article-title>Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis</article-title>. <source>Scand J Infect Dis</source> (<year>2006</year>) <volume>38</volume>(<issue>3</issue>):<fpage>205</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1080/00365540500263268</pub-id><?supplied-pmid 16500782?><pub-id pub-id-type="pmid">16500782</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farah</surname><given-names>R</given-names></name><name><surname>Awad</surname><given-names>J</given-names></name></person-group>. <article-title>The association of interferon with the development of pulmonary tuberculosis</article-title>. <source>Int J Clin Pharmacol Ther</source> (<year>2007</year>) <volume>45</volume>(<issue>11</issue>):<fpage>598</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="doi">10.5414/CPP45598</pub-id><?supplied-pmid 18077924?><pub-id pub-id-type="pmid">18077924</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telesca</surname><given-names>C</given-names></name><name><surname>Angelico</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>P</given-names></name><name><surname>Nosotti</surname><given-names>L</given-names></name><name><surname>Morrone</surname><given-names>A</given-names></name><name><surname>Longhi</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant</article-title>. <source>J Infect</source> (<year>2007</year>) <volume>54</volume>(<issue>4</issue>):<fpage>e223</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jinf.2006.12.009</pub-id><?supplied-pmid 17307255?><pub-id pub-id-type="pmid">17307255</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkahla</surname><given-names>N</given-names></name><name><surname>Kchir</surname><given-names>H</given-names></name><name><surname>Maamouri</surname><given-names>N</given-names></name><name><surname>Ouerghi</surname><given-names>H</given-names></name><name><surname>Hariz</surname><given-names>FB</given-names></name><name><surname>Chouaib</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>[Reactivation of tuberculosis during dual therapy with pegylated interferon and ribavirin for chronic hepatitis C]</article-title>. <source>Rev Med Interne</source> (<year>2010</year>) <volume>31</volume>(<issue>11</issue>):<fpage>e1</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1016/j.revmed.2009.11.017</pub-id><?supplied-pmid 20605283?><pub-id pub-id-type="pmid">20605283</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardigni</surname><given-names>V</given-names></name><name><surname>Fabbri</surname><given-names>G</given-names></name><name><surname>Grilli</surname><given-names>A</given-names></name><name><surname>Contini</surname><given-names>C</given-names></name></person-group>. <article-title>Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports</article-title>. <source>Ann Hepatol</source> (<year>2012</year>) <volume>11</volume>(<issue>3</issue>):<fpage>404</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 22481462?><pub-id pub-id-type="pmid">22481462</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmero</surname><given-names>D</given-names></name><name><surname>Eiguchi</surname><given-names>K</given-names></name><name><surname>Rendo</surname><given-names>P</given-names></name><name><surname>Castro Zorrilla</surname><given-names>L</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>Gonzalez Montaner</surname><given-names>LJ</given-names></name></person-group>. <article-title>Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up</article-title>. <source>Int J Tuberc Lung Dis</source> (<year>1999</year>) <volume>3</volume>(<issue>3</issue>):<fpage>214</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 10094322?><pub-id pub-id-type="pmid">10094322</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Ameglio</surname><given-names>F</given-names></name><name><surname>Zangrilli</surname><given-names>P</given-names></name><name><surname>Palla</surname><given-names>M</given-names></name><name><surname>Altieri</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis</article-title>. <source>Eur Cytokine Netw</source> (<year>2000</year>) <volume>11</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>104</lpage>.<?supplied-pmid 10705306?><pub-id pub-id-type="pmid">10705306</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Alemanno</surname><given-names>L</given-names></name><name><surname>Galluccio</surname><given-names>G</given-names></name><name><surname>Mattia</surname><given-names>P</given-names></name><name><surname>Pedicelli</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1998</year>) <volume>158</volume>(<issue>4</issue>):<fpage>1156</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.158.4.9803065</pub-id><?supplied-pmid 9769275?><pub-id pub-id-type="pmid">9769275</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansoori</surname><given-names>D</given-names></name><name><surname>Tavana</surname><given-names>S</given-names></name><name><surname>Mirsaeidi</surname><given-names>M</given-names></name><name><surname>Yazdanpanah</surname><given-names>M</given-names></name><name><surname>Sohrabpour</surname><given-names>H</given-names></name></person-group>
<article-title>The efficacy of interferon-&#x003b1; in the treatment of multidrug resistant tuberculosis</article-title>. <source>Tanaffos</source> (<year>2002</year>) <volume>1</volume>(<issue>3</issue>):<fpage>29</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarogoulidis</surname><given-names>P</given-names></name><name><surname>Kioumis</surname><given-names>I</given-names></name><name><surname>Papanas</surname><given-names>N</given-names></name><name><surname>Manika</surname><given-names>K</given-names></name><name><surname>Kontakiotis</surname><given-names>T</given-names></name><name><surname>Papagianis</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature</article-title>. <source>J Chemother</source> (<year>2012</year>) <volume>24</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1179/1973947812y.0000000005</pub-id><?supplied-pmid 22759763?><pub-id pub-id-type="pmid">22759763</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Skinner</surname><given-names>JA</given-names></name><name><surname>Baldwin</surname><given-names>N</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Lin</surname><given-names>PL</given-names></name></person-group>. <article-title>Early whole blood transcriptional signatures are associated with severity of lung inflammation in cynomolgus macaques with <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>(<issue>12</issue>):<fpage>4817</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601138</pub-id><?supplied-pmid 27837110?><pub-id pub-id-type="pmid">27837110</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group>. <article-title>Cytokine and lipid mediator networks in tuberculosis</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>264</volume>(<issue>1</issue>):<fpage>264</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12249</pub-id><?supplied-pmid 25703565?><pub-id pub-id-type="pmid">25703565</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>KL</given-names></name><name><surname>Anis</surname><given-names>FZ</given-names></name><name><surname>Sarmiento</surname><given-names>ME</given-names></name><name><surname>Norazmi</surname><given-names>MN</given-names></name><name><surname>Acosta</surname><given-names>A</given-names></name></person-group>. <article-title>Role of interferons in the development of diagnostics, vaccines, and therapy for tuberculosis</article-title>. <source>J Immunol Res</source> (<year>2017</year>) <volume>2017</volume>:<fpage>5212910</fpage>.<pub-id pub-id-type="doi">10.1155/2017/5212910</pub-id><?supplied-pmid 28713838?><pub-id pub-id-type="pmid">28713838</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariotti</surname><given-names>S</given-names></name><name><surname>Teloni</surname><given-names>R</given-names></name><name><surname>Iona</surname><given-names>E</given-names></name><name><surname>Fattorini</surname><given-names>L</given-names></name><name><surname>Romagnoli</surname><given-names>G</given-names></name><name><surname>Gagliardi</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>(<issue>8</issue>):<fpage>4385</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1128/iai.72.8.4385-4392.2004</pub-id><?supplied-pmid 15271894?><pub-id pub-id-type="pmid">15271894</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchonnet</surname><given-names>F</given-names></name><name><surname>Boechat</surname><given-names>N</given-names></name><name><surname>Bonay</surname><given-names>M</given-names></name><name><surname>Hance</surname><given-names>AJ</given-names></name></person-group>. <article-title>Alpha/beta interferon impairs the ability of human macrophages to control growth of <italic>Mycobacterium bovis</italic> BCG</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>(<issue>6</issue>):<fpage>3020</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.70.6.3020-3025.2002</pub-id><?supplied-pmid 12010993?><pub-id pub-id-type="pmid">12010993</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>(<issue>6126</issue>):<fpage>1448</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><?supplied-pmid 23449998?><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Ewbank</surname><given-names>J</given-names></name><name><surname>Howes</surname><given-names>A</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Martirosyan</surname><given-names>A</given-names></name><name><surname>Ghilardi</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic>-infected macrophages</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>(<issue>7</issue>):<fpage>3600</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401088</pub-id><pub-id pub-id-type="pmid">25187652</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmey</surname><given-names>JM</given-names></name><name><surname>Campbell</surname><given-names>JA</given-names></name><name><surname>Weiss</surname><given-names>LA</given-names></name><name><surname>Monte</surname><given-names>KJ</given-names></name><name><surname>Lenschow</surname><given-names>DJ</given-names></name><name><surname>Stallings</surname><given-names>CL</given-names></name></person-group>. <article-title>The impact of ISGylation during <italic>Mycobacterium tuberculosis</italic> infection in mice</article-title>. <source>Microbes Infect</source> (<year>2017</year>) <volume>19</volume>(<issue>4&#x02013;5</issue>):<fpage>249</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2016.12.006</pub-id><?supplied-pmid 28087453?><pub-id pub-id-type="pmid">28087453</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogunovic</surname><given-names>D</given-names></name><name><surname>Byun</surname><given-names>M</given-names></name><name><surname>Durfee</surname><given-names>LA</given-names></name><name><surname>Abhyankar</surname><given-names>A</given-names></name><name><surname>Sanal</surname><given-names>O</given-names></name><name><surname>Mansouri</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency</article-title>. <source>Science</source> (<year>2012</year>) <volume>337</volume>(<issue>6102</issue>):<fpage>1684</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1224026</pub-id><pub-id pub-id-type="pmid">22859821</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Paus</surname><given-names>RA</given-names></name><name><surname>van Wengen</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Verdegaal</surname><given-names>EM</given-names></name><name><surname>van Dissel</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Inhibition of the type I immune responses of human monocytes by IFN-alpha and IFN-beta</article-title>. <source>Cytokine</source> (<year>2013</year>) <volume>61</volume>(<issue>2</issue>):<fpage>645</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2012.12.005</pub-id><pub-id pub-id-type="pmid">23299081</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchant</surname><given-names>A</given-names></name><name><surname>Amedei</surname><given-names>A</given-names></name><name><surname>Azzurri</surname><given-names>A</given-names></name><name><surname>Vekemans</surname><given-names>J</given-names></name><name><surname>Benagiano</surname><given-names>M</given-names></name><name><surname>Tamburini</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2001</year>) <volume>24</volume>(<issue>2</issue>):<fpage>187</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1165/ajrcmb.24.2.4274</pub-id><?supplied-pmid 11159053?><pub-id pub-id-type="pmid">11159053</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Geiger</surname><given-names>T</given-names></name><name><surname>Alkan</surname><given-names>S</given-names></name><name><surname>Heusser</surname><given-names>CH</given-names></name></person-group>
<article-title>Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells</article-title>. <source>J Exp Med</source> (<year>1993</year>) <volume>178</volume>(<issue>5</issue>):<fpage>1655</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1084/jem.178.5.1655</pub-id><pub-id pub-id-type="pmid">8228812</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavrochorianou</surname><given-names>N</given-names></name><name><surname>Evangelidou</surname><given-names>M</given-names></name><name><surname>Markogiannaki</surname><given-names>M</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Thyphronitis</surname><given-names>G</given-names></name><name><surname>Haralambous</surname><given-names>S</given-names></name></person-group>. <article-title>IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>) <volume>99</volume>(<issue>1</issue>):<fpage>175</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.3A1214-598R</pub-id><?supplied-pmid 26232452?><pub-id pub-id-type="pmid">26232452</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Stavropoulos</surname><given-names>E</given-names></name><name><surname>Ghilardi</surname><given-names>N</given-names></name><name><surname>Maynard</surname><given-names>CL</given-names></name><name><surname>Weaver</surname><given-names>CT</given-names></name><etal/></person-group>
<article-title>T cell-derived IL-10 impairs host resistance to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>(<issue>2</issue>):<fpage>613</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601340</pub-id><?supplied-pmid 28584007?><pub-id pub-id-type="pmid">28584007</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>T</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Heitmann</surname><given-names>L</given-names></name><name><surname>Rausch</surname><given-names>A</given-names></name><name><surname>Mages</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>(<issue>2</issue>):<fpage>1301</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0803567</pub-id><?supplied-pmid 19561100?><pub-id pub-id-type="pmid">19561100</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domingo-Gonzalez</surname><given-names>R</given-names></name><name><surname>Prince</surname><given-names>O</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name></person-group>. <article-title>Cytokines and chemokines in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Microbiol Spectr</source> (<year>2016</year>) <volume>4</volume>(<issue>5</issue>).<pub-id pub-id-type="doi">10.1128/microbiolspec.TBTB2-0018-2016</pub-id><?supplied-pmid 27763255?><pub-id pub-id-type="pmid">27763255</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienard</surname><given-names>J</given-names></name><name><surname>Movert</surname><given-names>E</given-names></name><name><surname>Valfridsson</surname><given-names>C</given-names></name><name><surname>Sturegard</surname><given-names>E</given-names></name><name><surname>Carlsson</surname><given-names>F</given-names></name></person-group>
<article-title>ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNgamma-mediated autophagy and growth restriction of intracellular mycobacteria</article-title>. <source>Cell Microbiol</source> (<year>2016</year>) <volume>18</volume>(<issue>10</issue>):<fpage>1471</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1111/cmi.12594</pub-id><pub-id pub-id-type="pmid">27062290</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremond</surname><given-names>CM</given-names></name><name><surname>Togbe</surname><given-names>D</given-names></name><name><surname>Doz</surname><given-names>E</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Vasseur</surname><given-names>V</given-names></name><name><surname>Maillet</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>2</issue>):<fpage>1178</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1178</pub-id><?supplied-pmid 17617611?><pub-id pub-id-type="pmid">17617611</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>SD</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Caspase-1 independent IL-1beta production is critical for host resistance to <italic>Mycobacterium tuberculosis</italic> and does not require TLR signaling in vivo</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>(<issue>7</issue>):<fpage>3326</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0904189</pub-id><?supplied-pmid 20200276?><pub-id pub-id-type="pmid">20200276</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Sada-Ovalle</surname><given-names>I</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><etal/></person-group>
<article-title>IL-1beta promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>(<issue>8</issue>):<fpage>4196</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202688</pub-id><pub-id pub-id-type="pmid">23487424</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Allele-specific induction of IL-1beta expression by C/EBPbeta and PU.1 contributes to increased tuberculosis susceptibility</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>(<issue>10</issue>):<fpage>e1004426</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004426</pub-id><pub-id pub-id-type="pmid">25329476</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilli</surname><given-names>M</given-names></name><name><surname>Arko-Mensah</surname><given-names>J</given-names></name><name><surname>Ponpuak</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Master</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>(<issue>2</issue>):<fpage>223</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.04.015</pub-id><?supplied-pmid 22921120?><pub-id pub-id-type="pmid">22921120</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>(<issue>6</issue>):<fpage>1023</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Rathinam</surname><given-names>VA</given-names></name><name><surname>Martens</surname><given-names>GW</given-names></name><name><surname>Martinot</surname><given-names>AJ</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><etal/></person-group>
<article-title>Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2474</pub-id><pub-id pub-id-type="pmid">23160153</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Bohsali</surname><given-names>A</given-names></name><name><surname>Ahlbrand</surname><given-names>SE</given-names></name><name><surname>Srinivasan</surname><given-names>L</given-names></name><name><surname>Rathinam</surname><given-names>VA</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name><etal/></person-group>
<article-title>Cutting edge: <italic>Mycobacterium tuberculosis</italic> but not nonvirulent mycobacteria inhibits IFN-beta and AIM2 inflammasome-dependent IL-1beta production via its ESX-1 secretion system</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>(<issue>7</issue>):<fpage>3514</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1301331</pub-id><pub-id pub-id-type="pmid">23997220</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiga</surname><given-names>H</given-names></name><name><surname>Kitada</surname><given-names>S</given-names></name><name><surname>Shimada</surname><given-names>Y</given-names></name><name><surname>Kamiyama</surname><given-names>N</given-names></name><name><surname>Okuyama</surname><given-names>M</given-names></name><name><surname>Makino</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Critical role of AIM2 in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Int Immunol</source> (<year>2012</year>) <volume>24</volume>(<issue>10</issue>):<fpage>637</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxs062</pub-id><?supplied-pmid 22695634?><pub-id pub-id-type="pmid">22695634</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McElvania Tekippe</surname><given-names>E</given-names></name><name><surname>Allen</surname><given-names>IC</given-names></name><name><surname>Hulseberg</surname><given-names>PD</given-names></name><name><surname>Sullivan</surname><given-names>JT</given-names></name><name><surname>McCann</surname><given-names>JR</given-names></name><name><surname>Sandor</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Granuloma formation and host defense in chronic <italic>Mycobacterium tuberculosis</italic> infection requires PYCARD/ASC but not NLRP3 or caspase-1</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>5</volume>(<issue>8</issue>):<fpage>e12320</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0012320</pub-id><?supplied-pmid 20808838?><pub-id pub-id-type="pmid">20808838</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Lauber</surname><given-names>J</given-names></name><name><surname>Blumenthal</surname><given-names>A</given-names></name><name><surname>Buer</surname><given-names>J</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name></person-group>. <article-title>Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2004</year>) <volume>84</volume>(<issue>3&#x02013;4</issue>):<fpage>144</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2003.12.003</pub-id><?supplied-pmid 15207484?><pub-id pub-id-type="pmid">15207484</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Lovewell</surname><given-names>RR</given-names></name><name><surname>Olive</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Eugenin</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis</article-title>. <source>Nat Microbiol</source> (<year>2017</year>) <volume>2</volume>:<fpage>17072</fpage>.<pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.72</pub-id><?supplied-pmid 28504669?><pub-id pub-id-type="pmid">28504669</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozza</surname><given-names>L</given-names></name><name><surname>Farinacci</surname><given-names>M</given-names></name><name><surname>Fae</surname><given-names>K</given-names></name><name><surname>Bechtle</surname><given-names>M</given-names></name><name><surname>Staber</surname><given-names>M</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to bacille Calmette-Guerin</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>1</issue>):<fpage>80</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343797</pub-id><pub-id pub-id-type="pmid">24114554</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozza</surname><given-names>L</given-names></name><name><surname>Farinacci</surname><given-names>M</given-names></name><name><surname>Bechtle</surname><given-names>M</given-names></name><name><surname>Staber</surname><given-names>M</given-names></name><name><surname>Zedler</surname><given-names>U</given-names></name><name><surname>Baiocchini</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Communication between human dendritic cell subsets in tuberculosis: requirements for naive CD4(+) T cell stimulation</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>324</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00324</pub-id><pub-id pub-id-type="pmid">25071784</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalie</surname><given-names>E</given-names></name><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>Podoplelova</surname><given-names>Y</given-names></name><name><surname>Piehler</surname><given-names>J</given-names></name><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>. <article-title>The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities</article-title>. <source>J Biol Chem</source> (<year>2008</year>) <volume>283</volume>(<issue>47</issue>):<fpage>32925</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M806019200</pub-id><?supplied-pmid 18801736?><pub-id pub-id-type="pmid">18801736</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strunk</surname><given-names>JJ</given-names></name><name><surname>Gregor</surname><given-names>I</given-names></name><name><surname>Becker</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Gavutis</surname><given-names>M</given-names></name><name><surname>Jaks</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain</article-title>. <source>J Mol Biol</source> (<year>2008</year>) <volume>377</volume>(<issue>3</issue>):<fpage>725</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/j.jmb.2008.01.017</pub-id><?supplied-pmid 18294654?><pub-id pub-id-type="pmid">18294654</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Weerd</surname><given-names>NA</given-names></name><name><surname>Vivian</surname><given-names>JP</given-names></name><name><surname>Nguyen</surname><given-names>TK</given-names></name><name><surname>Mangan</surname><given-names>NE</given-names></name><name><surname>Gould</surname><given-names>JA</given-names></name><name><surname>Braniff</surname><given-names>SJ</given-names></name><etal/></person-group>
<article-title>Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>9</issue>):<fpage>901</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2667</pub-id><pub-id pub-id-type="pmid">23872679</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>KW</given-names></name><name><surname>Deng</surname><given-names>WL</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lowrie</surname><given-names>DB</given-names></name><etal/></person-group>
<article-title>The numerical predominance and large transcriptome differences of neutrophils in peripheral blood together inevitably account for a reported pulmonary tuberculosis signature</article-title>. <source>Int J Genomics</source> (<year>2017</year>) <volume>2017</volume>:<fpage>5830971</fpage>.<pub-id pub-id-type="doi">10.1155/2017/5830971</pub-id><?supplied-pmid 28265564?><pub-id pub-id-type="pmid">28265564</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Crotta</surname><given-names>S</given-names></name><name><surname>McCabe</surname><given-names>TM</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name></person-group>
<article-title>Pathogenic potential of interferon alphabeta in acute influenza infection</article-title>. <source>Nat Commun</source> (<year>2014</year>) <volume>5</volume>:<fpage>3864</fpage><pub-id pub-id-type="doi">10.1038/ncomms4864</pub-id><pub-id pub-id-type="pmid">24844667</pub-id></mixed-citation></ref></